How Penicillin Was Discovered and Developed

In September 1928, Alexander Fleming returned to his laboratory at St Mary's Hospital in London and noticed something odd on a culture plate. A mold had grown on a dish of Staphylococcus bacteria, and the bacteria near the mold had died. Fleming named the active substance penicillin in 1929. But a laboratory curiosity was far from a medicine, and the path from that observation to a mass-produced antibiotic took more than a decade. This article follows that path and explains why the discovery was only the first step.

What Fleming saw

Fleming was studying bacteria that cause boils, wounds and other infections. He kept cultures in dishes and sometimes left them open or stacked while he worked. When he came back from a vacation, he found a mold, later identified as a species of Penicillium, growing on one plate. A clear ring surrounded the mold where the Staphylococcus colonies had dissolved or failed to grow.

Fleming tested the mold's effect on many bacteria and published his findings in 1929 in the British Journal of Experimental Pathology. He called the active substance penicillin. He also noticed that it killed some harmful bacteria while leaving human white blood cells largely unharmed, which was an important early hint about its potential as a treatment.

Why the discovery stalled

Fleming's observation was real, but he could not turn it into a drug. Penicillin was unstable, present in very small amounts in the broth, and difficult to separate from other substances. Fleming was a bacteriologist, not a chemist with the tools to purify and stabilize such a compound. He tried for some time to extract it, but progress was slow and frustrating.

Many scientists read his paper without seeing its practical value. Infections were common and deadly, but the chemical tools for making a safe drug from a mold did not yet exist. The discovery sat in the literature for more than a decade while other researchers worked on sulfonamide drugs and other early antibacterial agents.

Florey, Chain and Heatley at Oxford

The revival came at the University of Oxford in the late 1930s. Howard Florey led a team of pathologists that included Ernst Chain, a biochemist, and Norman Heatley, who was skilled at building and improvising laboratory equipment. The team wanted to understand how natural substances fight infection, and they returned to Fleming's old paper.

Heatley developed methods to extract penicillin from broth and then move it back into a smaller volume of liquid, which concentrated it. He improvised apparatus from ordinary materials, and the team's work relied on a steady supply of cultures and careful chemistry. By 1940, the Oxford group had produced enough penicillin to test in animals and then in humans.

The first patients

In February 1941, the team gave penicillin to a police constable in Oxford who had a severe infection after a scratch from a rose bush. He improved quickly, but the supply ran out and he later died. The case showed that penicillin could work in people, and it also showed that the drug would have to be produced in far larger quantities.

Further trials in 1942 and 1943 gave clearer results. Patients with serious infections recovered in cases that had previously been fatal, and researchers began to see the drug's full potential. Medicine had a new class of treatment, but it still lacked the factories needed to supply it widely.

Mass production in wartime

The United States entered the search for production methods during the Second World War. Scientists at the Northern Regional Research Laboratory in Peoria, Illinois, worked with American pharmaceutical companies to improve yields. A widely repeated story says that one key high-yield strain came from a moldy cantaloupe found at a local market, although the details of that account vary between sources.

Engineers developed deep-tank fermentation, which grew the mold in large vats with controlled air and nutrients. Yields rose enormously over a few years. Companies such as Merck, Pfizer and Squibb competed and cooperated to meet military demand for wounded soldiers. The drug became widely available to the Allied forces by the mid-1940s.

Stage	Approximate year	Key people or group	Main step
Observation	1928	Alexander Fleming	Clear zone around mold
Publication	1929	Alexander Fleming	Named penicillin
Revival	1939 to 1940	Florey, Chain, Heatley	Extraction and testing
First patient	1941	Oxford team	Early human treatment
Mass production	1943 to 1945	US labs and companies	Deep-tank fermentation

The Nobel Prize and the warning

In 1945, Fleming, Florey and Chain shared the Nobel Prize in Physiology or Medicine. Fleming's Nobel lecture included a warning that became one of his most cited statements. He worried that too little penicillin, taken for too short a time, could allow bacteria to become resistant to the drug. Resistance became a serious problem in later decades, and it remains a central concern in modern medicine.

Fleming's warning shows that he understood the limits of his discovery even as the drug changed medicine. A powerful antibiotic can lose its power if it is misused, and its benefits depend on careful prescribing and full courses of treatment.

Why the discovery mattered

Penicillin changed the treatment of infection. Before it, a simple cut, a childbirth complication or a pneumonia could kill. Surgeons gained confidence in operations that carried high risk of infection. Doctors could treat wounded soldiers and civilians with a drug that worked quickly and reliably against many bacteria.

The timeline also shows why each stage was slow. Fleming's 1929 paper gave the idea, but the chemistry needed to purify the substance did not exist in usable form until the late 1930s. Clinical testing then required careful dosing, safety checks and enough supply to treat patients over several weeks. Production needed fermentation engineers, factories and government contracts. Each stage depended on the previous one, and a delay at any point could have stopped the whole chain.

The story also shows how science works in practice. A careful observation can start a discovery, but it often needs other people with different skills to turn it into something useful. Fleming saw the mold. Florey, Chain and Heatley made the drug. Engineers and companies made it available to millions.

Key takeaways

Fleming noticed a mold that killed bacteria in 1928 and named its active substance penicillin in 1929. The discovery did not become a medicine until a team at Oxford purified the compound and tested it in people in the early 1940s. Wartime mass production turned a lab result into a drug that saved many lives.

The history of penicillin shows that discovery is only one part of progress. Chemistry, engineering, clinical testing and public health all had to work together. It also shows that the drug's success brings responsibility, because its power depends on how carefully it is used.